BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37528481)

  • 1. TFE3 nuclear expression as a novel biomarker of ovarian sclerosing stromal tumors and associated with its histological morphology.
    Zhao L; Yang Z; Zhou Y; Liu Y; Luo Q; Jiang Q; Wang H; Wang N
    J Ovarian Res; 2023 Aug; 16(1):152. PubMed ID: 37528481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TFE3 is a Novel Biomarker of Ovarian Sclerosing Stromal Tumours.
    Zhao L; Zhou Y; Liu Y; Luo Q; Jiang Q; Wang H; Wang N
    Res Sq; 2023 Feb; ():. PubMed ID: 36824738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on TFE3 Overexpression.
    Park CK; Kim HS
    Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian sex cord-stromal tumours and their mimics.
    Young RH
    Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors.
    Costa MJ; Morris R; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Aug; 117(8):802-8. PubMed ID: 7688213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogenetic consideration of ovarian sex cord-stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads.
    Park SH; Kim I
    Pathol Res Pract; 1994 May; 190(5):449-56. PubMed ID: 7527534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerosis in Sex Cord-Stromal Tumors Other Than the Sclerosing Stromal Tumor: A Report of 70 Cases.
    Devins KM; Young RH
    Am J Surg Pathol; 2023 Jul; 47(7):774-784. PubMed ID: 37184091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of inhibin in the identification of granulosa cell tumors of the ovary.
    Hildebrandt RH; Rouse RV; Longacre TA
    Hum Pathol; 1997 Dec; 28(12):1387-95. PubMed ID: 9416696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile.
    Tiltman AJ; Haffajee Z
    Int J Gynecol Pathol; 1999 Jul; 18(3):254-8. PubMed ID: 12090594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of 3 beta-hydroxysteroid dehydrogenase in sex cord-stromal tumors of the ovary.
    Sasano H; Mason JI; Sasaki E; Yajima A; Kimura N; Namiki T; Sasano N; Nagura H
    Int J Gynecol Pathol; 1990; 9(4):352-62. PubMed ID: 1700972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detailed histopathological characteristics of ovarian fibroma compared with thecoma, granulosa cell tumor, and sclerosing stromal tumor.
    Mobarki M; Papoudou-Bai A; Musawi S; Péoc'h M; Karpathiou G
    Pathol Res Pract; 2024 Apr; 256():155236. PubMed ID: 38447489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors.
    Choi YL; Kim HS; Ahn G
    Arch Pathol Lab Med; 2000 Apr; 124(4):563-9. PubMed ID: 10747314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
    Chen L; Yang B
    Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Review of Ovarian Sex Cord-Stromal Tumors.
    Hanley KZ; Mosunjac MB
    Surg Pathol Clin; 2019 Jun; 12(2):587-620. PubMed ID: 31097116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian tumors with endocrine function].
    Guo LN; Liu TH; Sun AJ; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Sex Cord-Stromal Tumors: Reflections on a 40-Year Experience With a Fascinating Group of Tumors, Including Comments on the Seminal Observations of Robert E. Scully, MD.
    Young RH
    Arch Pathol Lab Med; 2018 Dec; 142(12):1459-1484. PubMed ID: 30500284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid biosynthesis enzymes in ovarian sex-cord stromal tumors.
    Costa MJ; Morris R; Sasano H
    Int J Gynecol Pathol; 1994 Apr; 13(2):109-19. PubMed ID: 8005731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
    Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
    Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Buza N; Wong S; Hui P
    Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.